Vance Street Capital has acquired Injectech LLC for an undisclosed amount, completing a corporate acquisition that sees the investment firm gain ownership of a specialized manufacturer. This transaction signals Vance Street Capital’s strategic interest in expanding its holdings within the essential medical device supply chain and related industrial sectors.
Injectech LLC, founded in 1998 and based in Fort Collins, CO, has established itself as a trusted source for medical device OEMs, biomedical and pharmaceutical manufacturers, veterinary suppliers, and industrial businesses globally. The company manufactures a well-regarded line of plastic fittings, including luers, check valves, tube-to-tube connectors, and custom components. Injectech operates with an ISO 13485 certified quality management system, and all products are manufactured and packaged in an ISO Class 8 clean room, emphasizing its commitment to stringent quality and regulatory standards.
The acquisition is strategically significant for Vance Street Capital, integrating Injectech's specialized manufacturing capabilities, robust quality infrastructure, and strong market presence into its investment portfolio. Expected synergies include leveraging Injectech’s operational excellence and comprehensive product offerings to serve an even broader customer base. The move aims to capitalize on Injectech’s established reputation for precision manufacturing and reliability in critical fluid control applications, further solidifying its position within high-growth sectors.
The combined entity is positioned to build upon Injectech’s legacy of innovation and customer commitment. This transition is anticipated to support Injectech's continued growth, foster new product developments, and enhance its ability to meet the evolving demands of its diverse markets, ensuring a dependable supply of vital components.